arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

USA Rare Earth, Inc.

USAR

$19.48 ▲ +2.08 (+11.95%) at close

13 Visible periods

23 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, USA Rare Earth, Inc. shows weak fundamentals, weighed down by Interest Coverage and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $3.8B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC None

FCF / Share $-0.09

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$5.70M

— —

Net Income Profit after all expenses

$-66.99M

↓ -33.4% —

FCF / Share Free cash flow per share

$-0.09

↑ +41.4% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Interest CoverageInterest Coverage of -3500.18x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.16x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗
EPS Growth YoY (%)	N/M	-92.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-5366.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-3750.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-638.6% Weak ↑ Weak Improving Year-over-year change in net income	-8283.1% Weak Weak Year-over-year change in net income	-5387.3% Weak Weak Year-over-year change in net income	N/M	N/M	-30030.6% Weak ↑ Weak Improving Year-over-year change in net income	-41766.8% Weak Weak Year-over-year change in net income	-71994.1% Weak Weak Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	41.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	-36.6% Weak ↑ Weak Improving Year-over-year change in free cash flow	-25.3% Weak Weak Year-over-year change in free cash flow	-122.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗
Effective Tax Rate (%) (%)	0.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-323.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.28x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.56x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	-0.04x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	97.20x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗
Return on Invested Capital (%)	—	—	—	—	—	—	—	—	—	2.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	2.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	1.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-1.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-8.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-0.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-0.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	—	—	—	—	—	—	—	-23.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-298%)	0.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	0.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	-33.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-375%)

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗
Interest Coverage (x)	-1047.86x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-161.44x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-106.77x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-2.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-1.75B	$-359.93M	$-257.61M	$-121.79M	—	$-16.76M	—	—	—	—	$-337.59K	$-545.74K	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗
Revenue per Share (USD)	$0.03	—	—	—	$0.00	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.34	$-0.48	$-1.64	$-1.54	$0.75	$-0.25	$-0.03	$-0.04	$-0.11	—	—	—	$0.00
Free Cash Flow per Share (USD)	$-0.09	—	$-0.03	$-0.09	$-0.16	—	$-0.02	$-0.07	$-0.07	—	—	—	—
Book Value per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$0.00
Tangible Book Value per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$0.00
Basic Weighted Avg Shares (shares)	196.48M	—	102.59M	92.77M	64.46M	—	59.50M	59.42M	59.42M	—	—	—	5.50M

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗
Working Capital (USD)	$1.74B	$347.46M	$243.20M	$115.37M	—	$15.35M	—	—	—	$189.67K	$515.14K	$928.27K	—
Total Equity (USD)	—	—	—	—	—	—	—	—	—	$-12.91M	$-12.58M	$-12.17M	$18.80K

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗
Sales/Revenue/Turnover (USD)	$5.70M	—	—	—	$0.00	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$690.00K	$391.00K	$170.00K	$169.00K	$33.00K	$6.00K	$66.00K	$73.00K	$90.00K	—	—	—	—
Net Income, GAAP (USD)	$-66.99M	$-50.20M	$-156.68M	$-142.51M	$51.83M	$-6.80M	$-1.87M	$-2.60M	$-4.47M	$3.07M	$-6.20K	$-6.20K	$-6.20K
Operating Cash Flow (USD)	$-18.46M	$-27.90M	$-2.85M	$-7.91M	$-10.33M	$-3.50M	$-1.21M	$-4.04M	$-4.23M	$-136.92K	—	$-602.93K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 3 years · 13 quarters

USA Rare Earth, Inc.

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare USAR with peers